EKElif Kocaaga

Elif Kocaaga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elif Kocaaga has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Heart rate response and clinical determinants of Glittre activities of daily living test performance in pediatrics with cystic fibrosis

    by Cemile Bozdemir, Elif Kocaaga, Haluk Tekerlek, Deniz Inal-Ince, Hulya Arikan, Melda Saglam, Naciye Vardar-Yagli, Ebru Calik, Ugur Ozcelik, Deniz Dogru, et al.

    The Pediatric Glittre Activities of Daily Living Test (TGlittre-P) is a field test designed to assess the functional performance of activities of daily living (ADL) in pediatric patients with cystic fibrosis (CF). However, the effects of TGlittre-P on heart rate response and the clinical determinants of test performance in this population remain insufficiently understood. To compare the heart rate response elicited by the TGlittre-P and the six-minute walk test (6MWT), and to identify pulmonary and extrapulmonary factors associated with TGlittre-P performance in pediatric patients with CF. Fifty-four pediatric patients with CF (mean age = 14.46 ± 2.16 years, 31 females and 23 males) were included in this cross-sectional study. ADL performance was assessed using the TGlittre-P, and functional capacity was assessed using the 6MWT. Pulmonary function, including forced expiratory volume in one second (FEV₁) and forced vital capacity (FVC), maximal inspiratory and expiratory pressure (MIP and MEP, respectively), handgrip strength (HGS %) and quadriceps muscle strength (QMS %) were measured. A multiple linear regression analysis model was used to determine independent predictors of TGlittre-P performance. The mean TGlittre-P duration was 2.00 ± 0.53 min. There was agreement between recorded peak heart rate (HRpeak) responses during the TGlittre-P and 6MWT (mean difference: -2.33%, with limits of agreement ranging from − 41.19 to 36.52). HRpeak (bpm), HRpeak (% predicted HRmax), and pre-to-post changes in systolic and diastolic blood pressure (mmHg), oxygen saturation (%), and perceived effort were not different between TGlittre-P and 6MWT (p > 0.05). TGlittre-P duration (min) correlated with 6MWT distance (m), FEV1 (%), FEV1z-score, FVC (%), FVC z-score, MIP (cmH2O), MEP (cmH2O), HGS (%) and QMS (%) (p < 0.05). The FEV1 z-score, height z-score and sex were predictors for TGlittre-P duration (min) [Adjusted R2 = 0.402, F(3, 53) = 11.755, p < 0.001, constant = 1.625]. No significant differences were observed in the measured heart rate response between the TGlittre-P and 6MWT. TGlittre-P performance is strongly associated with pulmonary function and respiratory and peripheral muscle strength. Airway obstruction was the strongest predictor of TGlittre-P performance in this population.

  • Physiological responses to cardiopulmonary and field exercise tests in primary ciliary dyskinesia compared with healthy peers

    by Aslihan Cakmak-Onal, Elif Kocaaga, Hazal Sonbahar-Ulu, Ebru Calik, Naciye Vardar-Yagli, Melda Saglam, Birce Sunman, Nagehan Emiralioglu, Ugur Ozcelik, Deniz Inal-Ince

    Purpose Primary ciliary dyskinesia (PCD) is a rare disorder characterized by defective motile cilia, impairing airway mucociliary clearance. Children with PCD (cwPCD) may exhibit distinctions in exercise responses compared to healthy peers (HP). We aimed to compare physiological responses to cardiopulmonary exercise testing (CPET), incremental shuttle walk test (ISWT), and 6-min walk test (6MWT) in cwPCD and HP and investigate the associations between clinical parameters. Methods Twenty-three cwPCD and 23 HP were included. Pulmonary function and respiratory muscle strength were assessed. All participants performed CPET, ISWT, and 6MWT. Heart rate (HR), blood pressure (BP), oxygen saturation (SpO2), and dyspnea and fatigue (modified Borg Scale) were assessed before and after tests. Results In cwPCD, CPET and ISWT revealed similar HR, SpO2, systolic BP, dyspnea, and fatigue responses (p > 0.05), while 6MWT elicited lower responses in these parameters (p < 0.05). cwPCD had lower ∆HR (p = 0.003), peak oxygen uptake (peak\({\dot{\text{V}}\text{O}}_2\)) (p = 0.048), relative peak\({\dot{\text{V}}\text{O}}_2\) (p = 0.041), and higher minute ventilation/carbon dioxide production (V̇E/\({\dot{\text{V}}\text{CO}}_2\)) at anaerobic threshold (p = 0.047) compared to HP. Peak\({\dot{\text{V}}\text{O}}_2\) correlated with ISWT distance (ISWD) (r = 0.592) and 6MWT distance(6MWD) (r = 0.601) in cwPCD and HP (r = 0.648, r = 0.507, respectively) (p < 0.05). Regression equations were developed: relative peakV̇O₂ (mL/min/kg) = − 25.630 + 0.083 × 6MWD (m) [F(1–21) = 7.719, p = 0.011, R2 = 0.269] and relative peak\({\dot{\text{V}}\text{O}}_2\)(mL/min/kg) = 1.922 + 0.032 × ISWD(m) [F(1–21) = 11.790, p = 0.002, R2 = 0.329). Conclusion CPET and ISWT evoke comparable responses, while 6MWT results in lower physiological responses. However, 6MWT remains useful, given its association with peak\({\dot{\text{V}}\text{O}}_2\). The cwPCD have an altered \({\dot{\text{V}}}_E\) control and early CO2 increase with exercise, greater ventilatory inefficiency, and chronotropic impairment. Compared to field tests, CPET can be more helpful for determining ventilatory inefficiency and chronotropic impairment in PCD. ClinicalTrials.gov identifier NCT05712798 (Registration Date: 26.01.2023).


  • Validity and reliability of the Turkish version of the Bronchiectasis Health Questionnaire

    by Naciye Vardar-Yagli, Aslihan Cakmak-Onal, Elif Kocaaga, Merve Firat, Melda Saglam, Ebru Calik-Kutukcu, Deniz Inal-Ince


  • Late Breaking Abstract - Muscle oxygenation and cardiorespiratory responses during one and two-leg exercise tests in chronic obstructive pulmonary disease

    by Elif Kocaaga, Aslihan Cakmak-Onal, Oguz Karcioglu, Deniz Inal-Ince

    Background: Exercise tests are essential to determine exercise capacity in chronic obstructive pulmonary disease (COPD). Due to lower work, one-leg exercise tests (OLET) may be an alternative to two-leg exercise tests (TLET). Impaired muscle oxygenation (SmO2) in COPD leads to the early onset of leg fatigue during exercise. Objective: We aimed to compare SmO2 and cardiorespiratory responses to OLET and TLET in COPD. Methods: Ten males with COPD (age=66±6 years, FEV1=52±19%) were included. Lung function was assessed. OLET and TLET were performed incrementally at the cycle ergometer. Peak oxygen uptake (VO2peak) and work rate (Wpeak), ratio of air expired to carbon dioxide volume (VE/VCO2), O2pulse, oxygen saturation (SpO2), dyspnea and fatigue (modified Borg Scale), and SmO2 were measured before, during, and after tests. Results: VO2peak, Wpeak, and O2pulse were lower in OLET than in TLET (p>0.05). There were no significant differences in VE/VCO2, SpO2, dyspnea, fatigue, and SmO2 during OLET and TLET (p>0.05). Conclusions: OLET reveals lower VO2peak, Wpeak, and O2pulse despite similar dyspnea, fatigue perception, and SmO2. Due to its lower workload, tolerable fatigue, and perception of exertion, OLET may be a practical tool for assessing exercise capacity in COPD. erj;64/suppl_68/PA611/F1 F1 F1

  • Association between maximal and submaximal field tests in cystic fibrosis with impaired glucose tolerance

    by Elif Kocaaga, Cemile Bozdemir-Ozel, Dilber Ademhan-Tural, Ebru Calik-Kutukcu, Melda Saglam, Naciye Vardar-Yagli, Nagehan Emiralioglu, Ayfer Alikasifoglu, Deniz Dogru, Deniz Inal-Ince

    Background: Use of incremental shuttle walk test (ISWT) in cystic fibrosis with impaired glucose tolerance (CF-IGT) is infrequent. Aim: To compare ISWT and six-minute walk test (6MWT) findings in CF-IGT and to investigate relationship between exercise parameters, clinical characteristics, lung function, and muscle strength. Methods: Twenty-six patients with CF-IGT (mean age=14.5±2.2 years, mean FEV1=82±23%) were included. HbA1c (6.36±1.44%), fasting and postprandial glucose and insulin levels (109.7±48.8 mmol/l, 136.2±50.7 mmol/l, 7.5±8.2 µU/ml, and 46.9±43.8 µU/ml, respectively) were recorded. Lung function, maximal inspiratory and expiratory (MEP) muscle strength, and handgrip strength (HGS) were measured. Exercise capacity was assessed using 6MWT and ISWT. Changes in heart rate (HR), blood pressure (BP), and oxygen saturation (SpO2) were measured and dyspnea and fatigue perception (modified Borg Scale) were recorded before and after the tests. Results: 6MWT and ISWT distances were 564.6±138.3 m and 612.6±260.5 m, respectively (p=0.20). Intraclass correlation coefficient between tests was 0.794 (p1 (r=0.576), MEP (r=0.391), and HGS (r=0.452, p1 (r=0.611), MEP (r=0.425), HGS (r=0.526), and 6MWT distance (r=0.729, p<0.05). Conclusion: ISWT distance showed good correlation and consistency with 6MWT. It was associated with lung function, MEP, and HGS in patients with CF-IGT. ISWT can be used to assess exercise capacity in CF-IGT.

  • Relationship between anaerobic power and exercise capacity in cystic fibrosis with impaired glucose tolerance

    by Elif Kocaaga, Dilber Ademhan-Tural, Cemile Bozdemir-Ozel, Ebru Calik-Kutukcu, Naciye Vardar-Yagli, Melda Saglam, Deniz Dogru, Ayfer Alikasifoglu, Nagehan Emiralioglu, Deniz Inal-Ince

    Introduction: Few studies investigated the association between exercise capacity and anaerobic power in cystic fibrosis (CF). However, a study for anaerobic power in CF with abnormal glucose tolerance has yet to be found. This study aimed to identify the relationship between anaerobic power and exercise capacity in CF children with impaired glucose tolerance (IGT). Method: Twenty-nine CF patients with IGT (age=14.6±2.1 years, 14M, 15F, FEV1=82±23.4%) participated in the study. Lung function, glycosylated hemoglobin (HbA1c), and oral glucose tolerance test (OGTT) were recorded. An incremental shuttle walk test (ISWT) was performed. Anaerobic power was measured using a vertical jump test, and peak power was calculated. Result: The mean ISWT distance was 614.8±256.9 m, and the %ISWT distance was 47.7±20.8%. Peak power was 4720.58±588.91 Watt. A significant correlation was found between peak power and ISWT distance (r=0.455, p=0.017), FEV1 (r=0.564, p=0.001), FVC (r=0.661, p<0.001), PEF (r=0.649 p<0.001), and FEF25-75% (r=0.491, p=0.007). There was a significant relationship between ISWT distance and FEV1 (r=0.676, p<0.001), FVC (r=0.663, p<0.001), PEF (r=0.594, p=0.001), and FEF25-75% (r=0.563, p=0.002). Conclusion: This study observed anaerobic power correlated with exercise capacity measured with ISWT in CF with IGT. Since the glucose mechanism is essential to both anaerobic and aerobic performance, whether anaerobic exercise training may help to increase aerobic capacity in CF with IGT needs further investigation. Supported by Hacettepe University Scientific Research Project Coordination Unit.

  • Open Access

    Upper Extremity Exercise Capacity and Activities of Daily Living in Individuals with Bronchiectasis Versus Healthy Controls

    by Aslihan Cakmak, Elif Kocaaga, Hazal Sonbahar-Ulu, Deniz Inal-Ince, Naciye Vardar-Yagli, Ebru Calik-Kutukcu, Melda Saglam, Lutfi Coplu

    The purpose of this study was to compare the upper extremity exercise capacity and activities of daily living (ADLs) in individuals with bronchiectasis and controls. Twenty-four individuals with bronchiectasis and 24 healthy controls were assessed for upper extremity exercise capacity (6-minute pegboard and ring test [6PBRT]) and ADLs (Glittre ADL test). Energy expenditure was measured using a wearable metabolic monitor during the Glittre ADL test. The mean 6PBRT score of individuals with bronchiectasis was significantly lower than the mean score of controls (196.50 [SD = 51.75] versus 243.00 [SD = 29.76] number of rings). The Glittre ADL test duration was significantly higher in individuals with bronchiectasis compared with controls (3.54 [SD = 1.53] versus 2.36 [SD = 0.18] min), despite similar energy expenditure during the Glittre ADL test between the groups (17.67 [SD = 5.28] kcal in individuals with bronchiectasis versus 18.13 [SD = 5.71] kcal in controls). The 6PBRT score and the Glittre ADL test duration were negatively correlated in individuals with bronchiectasis (r = −0.694). The individuals with bronchiectasis had reduced upper extremity exercise capacity compared with healthy controls. Energy expenditure during ADLs was similar between individuals with bronchiectasis and healthy controls, despite lower ADL performance in individuals with bronchiectasis. The upper extremity exercise capacity and ADLs are related in individuals with bronchiectasis. Given the relationship between upper extremity exercise capacity and ADLs in bronchiectasis, inclusion of upper extremity exercise training to pulmonary rehabilitation programs should be considered. Considering the impairment of upper extremity exercise capacity and ADLs in individuals with bronchiectasis highlights the necessity to tailor preventive strategies and preclude further unfavorable effects. Bronchiectasis may cause deterioration in upper extremity exercise capacity and ADLs. The assessment of upper exercise capacity and ADLs by physical therapists in individuals with bronchiectasis may be useful for designing comprehensive rehabilitation programs and thus the management of bronchiectasis.


  • Exercise performance in children and adolescents with cystic fibrosis with and without abnormal glucose tolerance: a single center cross-sectional study

    by Elif Kocaaga, Deniz Inal-Ince, Deniz Dogru, Ayfer Alikasifoglu, Dilber Ademhan-Tural, Cemile Bozdemir-Ozel, Ebru Calik-Kutukcu, Melda Saglam, Naciye Vardar-Yagli, Nagehan Emiralioglu

    Abnormal glucose tolerance (AGT) in cystic fibrosis (CF) affects lung function and clinical parameters, including aerobic fitness. However, its effects on physical activity level (PAL), anaerobic power (AP), and muscle strength (MS) in children and adolescents are unknown. To investigate aerobic fitness, PAL, AP, and MS in pediatric patients with mild-to-moderate CF and AGT. The study included children and adolescents with CF aged 10–18 years. Participants underwent a pulmonary function test, quadriceps, and handgrip MS measurement, vertical jump test to assess AP, and six-minute walk test (6MWT) to assess aerobic fitness. Bouchard’s Three-Day Physical Activity record was used to determine PAL. Height z-score (p = .006), 6MWT (p = .024), handgrip (p = .028), quadriceps MS (p = .044), and AP (p = .036) were significantly lower in AGT (n = 21) than normal glucose tolerance (NGT) (n = 19). In the AGT group, glycosylated hemoglobin (HbA1c) was significantly associated with forced expiratory volume in one second (FEV1) (p = .046). 6MWT distance (6MWD) was associated with height (p = .008), FEV1 (p = .001), forced vital capacity (FVC) (p = .001), forced expiratory flow from 25% to 75% (FEF25-75%) (p = .030), handgrip MS (p = .012), and PAL (p = .034). After adjusting for height and FEV1, the groups had similar 6MWD, MS, and AP (p > .05); also, insulin was associated with MS and AP but not with 6MWT or quadriceps MS. Measures of aerobic fitness, MS, and AP are lower in AGT, but after adjusting for height and FEV1, aerobic fitness, MS, and AP do not show substantial differences. Insulin sensitivity and resistance are associated with MS and AP.


  • Physical activity, functional capacity, and anaerobic power in cystic fibrosis with and without impaired glucose tolerance

    by Elif Kocaaga, Deniz Inal-Ince, Dilber Ademhan-Tural, Cemile Bozdemir-Ozel, Ebru Calik-Kutukcu, Naciye Vardar-Yagli, Melda Saglam, Deniz Dogru, Ayfer Alikasifoglu, Nagehan Emiralioglu

    Introduction: There are few studies investigating the effects of abnormal glucose tolerance on functional capacity and physical activity in cystic fibrosis (CF) but yet not found a study for anaerobic power. Therefore, we aimed to compare physical activity, functional capacity, and anaerobic power in CF patients with and without impaired glucose tolerance. Method: Twenty-seven (13 M, 14F, aged 10-18 years) CF patients with impaired (CF-IGT) and 19 CF patients (11M, 8F, aged 10-17 years) without impaired glucose tolerance (CF-NGT) participated in the study. Lung function, glycated hemoglobin (HbA1c), and oral glucose tolerance test (OGTT) findings were recorded. A six-minute walk test (6MWT) was performed, and heart rate, oxygen saturation (SpO2), blood pressure, dyspnea, general, and leg fatigue using the modified Borg Scale were measured before and after the test. Anaerobic power was assessed using a vertical jump test. Peak power and average power were calculated. Bouchard Physical Activity Record was used for the assessment of physical activity level. Result: The CF-IGT group had a lower FEV1 (p=0.030) and FEF25-75% (p=0.015). The CF-IGT had a lower 6MWT distance (p=0.003), peak anaerobic power (p=0.027), and physical activity level (p=0.014) than those of CF-NGT patients. Conclusion: Physical activity, functional capacity, anaerobic power, and lung function reduced in CF patients with impaired glucose levels. Lung function is effected from increased glucose level in airway. Reduced physical activity, functional capacity, and anaerobic power may be related to disturbed skeletal muscle glucose anabolism.